PMEL and melanoma: It possesses a highly specific T cell receptor that recognizes an HLA-A0201-presented peptide of the melanocytic differentiation antigen glycoprotein 100 (gp100), which is expressed in normal melanocytes as well as melanoma cells, and is fused to a CD3 antibody that binds and activates T cells [4].